BiocurePharm is Biopharmaceutical venture company that has a target to overcome incurable disease.
HSA-TIMP-2(Human Serum Albumin-Tissue Inhibitor Metalloproteinase-2), a remedy for the cancer, is the most emphasizing new medicine project in Biocurepharm.

  Construction of HSA-TIMP-2

  TIMP-2 inhibits endothelial cell growth by binding to a3b1

  Expected Application: Lung cancer, Pancreatic cancer, Breast cancer